A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon OncoSignature? Status

Is This Study For You?

Let's Get Started!

Details
Age
Adult
Locations

CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Lindsay Brubaker

Lindsay Brubaker

Study ID

Protocol Number: 23-0115

More information available at ClinicalTrials.gov: NCT05548296

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers